![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 27, 25512-25516, July 8, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Aminobutyric Acid Transporter GAT-1 Inferred from Paired Cysteine Mutagenesis*

From the Department of Biochemistry, Hebrew University Hadassah Medical School, Jerusalem 91120, Israel
GAT-1 is a sodium- and chloride-dependent
-aminobutyric acid
transporter and is the first identified member of a family of transporters
that maintain low synaptic neurotransmitter levels and thereby enable
efficient synaptic transmission. Because transmembrane domains 1 and 3 contain
amino acid residues important for transport activity, we hypothesized that
these domains may participate in the formation of the binding pocket of the
transporter. Pairwise substitutions have been introduced in several predicted
transmembrane domains and in the first extracellular loop of GAT-1. In the
double mutant W68C/I143C, in which the cysteines were introduced at locations
at the extracellular part of transmembrane domains 1 and 3, respectively,
70% inhibition of transport was observed by cadmium with an
IC50 of
10 µM. This inhibition was not observed
in the corresponding single mutants and also not in >10 other double
mutants, except for V67C/I143C, where the half-maximal effect was obtained at
50 µM. The inhibition by cadmium was only observed when the
cysteine pairs were introduced in the same polypeptide. Our results suggest
that transmembrane domains 1 and 3 come in close proximity within the
transporter monomer.
Received for publication, April 11, 2005 , and in revised form, May 18, 2005.
* This work was supported by The Israel Science Foundation Grant 488/03-16.1 and the Bernard Katz Minerva Center for Cellular Biophysics. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry, Hebrew
University Hadassah Medical School, Jerusalem 91120, Israel. Tel.:
972-2-6758506; Fax: 972-2-6757379; E-mail:
kannerb{at}cc.huji.ac.il.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Qu and B. I. Kanner Substrates and Non-transportable Analogues Induce Structural Rearrangements at the Extracellular Entrance of the Glial Glutamate Transporter GLT-1/EAAT2 J. Biol. Chem., September 26, 2008; 283(39): 26391 - 26400. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rosenberg and B. I. Kanner The Substrates of the {gamma}-Aminobutyric Acid Transporter GAT-1 Induce Structural Rearrangements around the Interface of Transmembrane Domains 1 and 6 J. Biol. Chem., May 23, 2008; 283(21): 14376 - 14383. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. White, P. D. Kiser, D. E. Nichols, and E. L. Barker Engineered zinc-binding sites confirm proximity and orientation of transmembrane helices I and III in the human serotonin transporter. Protein Sci., October 1, 2006; 15(10): 2411 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Henry, J. R. Field, E. M. Adkins, M. L. Parnas, R. A. Vaughan, M.-F. Zou, A. H. Newman, and R. D. Blakely Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants J. Biol. Chem., January 27, 2006; 281(4): 2012 - 2023. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |